NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

36.53

-0.47 (-1.27%)

Nov 4, 2025, 4:00 PM EST - Market closed

NAMS Employees

NewAmsterdam Pharma Company had 68 employees as of December 31, 2024. The number of employees increased by 39 or 134.48% compared to the previous year.

Employees

68

Change (1Y)

39

Growth (1Y)

134.48%

Revenue / Employee

$941,265

Profits / Employee

-$2,436,985

Market Cap

4.11B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	68	39	134.48%
Dec 31, 2023	29	12	70.59%
Dec 31, 2022	17	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

NAMS News

5 days ago - NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in November - GlobeNewsWire
5 weeks ago - NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum - GlobeNewsWire
2 months ago - NewAmsterdam Pharma Company N.V. (NAMS) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
2 months ago - NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September - GlobeNewsWire
2 months ago - Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - PRNewsWire
2 months ago - NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib - GlobeNewsWire
3 months ago - NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewsWire
3 months ago - NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer's Disease Biomarkers at AAIC 2025 - GlobeNewsWire